The Concept of Euthymia

Well-Being Therapy: Current Indications and Emerging Perspectives

“…She defined it as the individual's balance of psychic forces (flexibility), a unifying outlook on life which guides actions and feelings for shaping the future accordingly, and resistance to stress (resilience and anxiety or frustration tolerance). It is not simply generic (and clinically useless) advice of avoiding excesses and extremes; it is how the individual adjusts the psychological dimensions of well-being to changing needs [18]. …”

“…Patients are not simply encouraged to pursue the highest possible levels in psychological well-being in all dimensions, as is found to be the case in most positive interventions [20], but to obtain a balanced functioning, subsumed under the rubric of euthymia [18]. Positive characteristics such as gratitude and autonomy often exist on a continuum [23].…”

Adjunctive Brexpiprazole in Patients With Major Depressive Disorder and Irritability

“…Addressing the whole spectrum of residual symptoms is very important clinically, as the ultimate goal of antidepressant therapy is euthymia. 25 Symptoms of the irritability, anger-hostility, and depressive symptoms reemerged after discontinuation of brexpiprazole, although not to same severity level observed at baseline, suggesting a direct effect of treatment on the broad cluster of symptoms. The overall improvement in the Barratt Impulsiveness Scale during brexpiprazole treatment is difficult to interpret, and the continued modest improvement after discontinuation of brexpiprazole perhaps reflects more the impulsive traits of personality rather than the severity of current symptoms or direct effects of the drug.…”

Clinical Pharmacopsychology: Conceptual Foundations and Emerging Tasks

“…Further, high sensitivity is required for detecting residual symptomatology, which was found to characterize the majority of patients who were judged to be remitted according to DSM criteria and no longer in need of active treatment [39]. Excessive reliance on symptoms that are part of diagnostic criteria of mental disorders (e.g., major depressive disorder, generalized anxiety disorder) has impoverished clinical assessment in psychopharmacology and does not reflect the broad spectrum of variables that affect clinical presentations: subclinical distress [39], such as demoralization and irritable mood [40], psychological well-being and euthymia [41,42,43], mental pain [44,45,46,47], social adjustment [48], and neuroticism [49,50]. …”